171 related articles for article (PubMed ID: 36917470)
1. Direct Measurement of Nucleoside Ribohydrolase Enzyme Activities in
Stockman BJ; Ventura CA; Deykina VS; Khayan Lontscharitsch N; Saljanin E; Gil A; Canestrari M; Mahmood M
Anal Chem; 2023 Mar; 95(12):5300-5306. PubMed ID: 36917470
[TBL] [Abstract][Full Text] [Related]
2. Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.
Muellers SN; Gonzalez JA; Kaur A; Sapojnikov V; Benzie AL; Brown DG; Parkin DW; Stockman BJ
ACS Infect Dis; 2019 Mar; 5(3):345-352. PubMed ID: 30701958
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of purine and pyrimidine transport activities in Trichomonas vaginalis and functional cloning of a trichomonad nucleoside transporter.
Natto MJ; Miyamoto Y; Munday JC; AlSiari TA; Al-Salabi MI; Quashie NB; Eze AA; Eckmann L; De Koning HP
Mol Microbiol; 2021 Dec; 116(6):1489-1511. PubMed ID: 34738285
[TBL] [Abstract][Full Text] [Related]
4. Trichomonas vaginalis NTPDase and ecto-5'-nucleotidase hydrolyze guanine nucleotides and increase extracellular guanosine levels under serum restriction.
Menezes CB; Durgante J; de Oliveira RR; Dos Santos VH; Rodrigues LF; Garcia SC; Dos Santos O; Tasca T
Mol Biochem Parasitol; 2016 May; 207(1):10-8. PubMed ID: 27150347
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Ligand-Efficient Scaffolds for the Design of Novel
Auletta S; Caravan W; Persaud JK; Thuilot SF; Brown DG; Parkin DW; Stockman BJ
ACS Omega; 2019 Oct; 4(14):16226-16232. PubMed ID: 31592163
[TBL] [Abstract][Full Text] [Related]
6. Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.
Alam R; Barbarovich AT; Caravan W; Ismail M; Barskaya A; Parkin DW; Stockman BJ
Chem Biol Drug Des; 2018 Oct; 92(4):1736-1742. PubMed ID: 29808562
[TBL] [Abstract][Full Text] [Related]
7. Structure-Guided Insight into the Specificity and Mechanism of a Parasitic Nucleoside Hydrolase.
Muellers SN; Nyitray MM; Reynarowych N; Saljanin E; Benzie AL; Schoenfeld AR; Stockman BJ; Allen KN
Biochemistry; 2022 Sep; 61(17):1853-1861. PubMed ID: 35994320
[No Abstract] [Full Text] [Related]
8. A riboside hydrolase that salvages both nucleobases and nicotinamide in the auxotrophic parasite Trichomonas vaginalis.
Patrone M; Galasyn GS; Kerin F; Nyitray MM; Parkin DW; Stockman BJ; Degano M
J Biol Chem; 2023 Sep; 299(9):105077. PubMed ID: 37482279
[TBL] [Abstract][Full Text] [Related]
9. Identification of a subversive substrate of Trichomonas vaginalis purine nucleoside phosphorylase and the crystal structure of the enzyme-substrate complex.
Zang Y; Wang WH; Wu SW; Ealick SE; Wang CC
J Biol Chem; 2005 Jun; 280(23):22318-25. PubMed ID: 15817485
[TBL] [Abstract][Full Text] [Related]
10. The purine nucleoside phosphorylase from Trichomonas vaginalis is a homologue of the bacterial enzyme.
Munagala N; Wang CC
Biochemistry; 2002 Aug; 41(33):10382-9. PubMed ID: 12173924
[TBL] [Abstract][Full Text] [Related]
11. Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
Beck S; Muellers SN; Benzie AL; Parkin DW; Stockman BJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5036-9. PubMed ID: 26592812
[TBL] [Abstract][Full Text] [Related]
12. Antiparasitic activity of furanyl N-acylhydrazone derivatives against Trichomonas vaginalis: in vitro and in silico analyses.
Alves MSD; das Neves RN; Sena-Lopes Â; Domingues M; Casaril AM; Segatto NV; Nogueira TCM; de Souza MVN; Savegnago L; Seixas FK; Collares T; Borsuk S
Parasit Vectors; 2020 Feb; 13(1):59. PubMed ID: 32046788
[TBL] [Abstract][Full Text] [Related]
13. Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.
Shea TA; Burburan PJ; Matubia VN; Ramcharan SS; Rosario I; Parkin DW; Stockman BJ
Bioorg Med Chem Lett; 2014 Feb; 24(4):1080-4. PubMed ID: 24468412
[TBL] [Abstract][Full Text] [Related]
14. Nucleoside uptake by Trichomonas vaginalis.
Harris DI; Beechey RB; Linstead D; Barrett J
Mol Biochem Parasitol; 1988 Jun; 29(2-3):105-16. PubMed ID: 2457803
[TBL] [Abstract][Full Text] [Related]
15. Deazapurine Nucleoside Analogues for the Treatment of
Natto MJ; Hulpia F; Kalkman ER; Baillie S; Alhejeli A; Miyamoto Y; Eckmann L; Van Calenbergh S; de Koning HP
ACS Infect Dis; 2021 Jun; 7(6):1752-1764. PubMed ID: 33974405
[TBL] [Abstract][Full Text] [Related]
16. Adenosine is the primary precursor of all purine nucleotides in Trichomonas vaginalis.
Munagala NR; Wang CC
Mol Biochem Parasitol; 2003 Apr; 127(2):143-9. PubMed ID: 12672523
[TBL] [Abstract][Full Text] [Related]
17. The Role of Purinergic Signaling in
Ferla M; Tasca T
Curr Top Med Chem; 2021; 21(3):181-192. PubMed ID: 32888270
[TBL] [Abstract][Full Text] [Related]
18. Phenolic chalcones as agents against Trichomonas vaginalis.
Oliveira LR; Trein MR; Assis LR; Rigo GV; Simões LPM; Batista VS; Macedo AJ; Trentin DS; Nascimento-Júnior NM; Tasca T; Regasini LO
Bioorg Chem; 2023 Dec; 141():106888. PubMed ID: 37839143
[TBL] [Abstract][Full Text] [Related]
19. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
[TBL] [Abstract][Full Text] [Related]
20. Persistent Trichomonas vaginalis infections and the pseudocyst form.
Shiratori M; Patel A; Gerhold RW; Sullivan SA; Carlton JM
Trends Parasitol; 2023 Dec; 39(12):1023-1031. PubMed ID: 37806787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
